Efficacy of the Telemedical Lifestyle intervention Program TeLiPro in Advanced Stages of Type 2 Diabetes: A Randomized Controlled Trial.
Source: Kempf, K., et al. 2017 - Pubmed ID: 28500214
Setting: Germany, Attending physician
Study design:
RCT
Follow up: 52 weeks
Patient group:
Sample size:
Total: 202 ( 133)
IG: 102 (77)
CG: 100 (56)
Inclusion criteria:
- Diabetes type 2
- Overweight or obese
Type of technology:
Home monitoring
- Weighing scale
- Step counter
- Blood glucose meter.
Webpage (TeLiPro device)
- Data upload
- Data transfer
Phone call
- Information
- Guidance
Intervention:
Intervention: Patients monitor and transfer their clinical data via TeLiPro device. Diabetes coaches calls patient weekly for discussion of measured data and for diabetes relevant information
Duration: 12 weeks
Add on: NA
Control group: Routine health care visits
Clinical effect:
- HbA1c ↓
- Body weight ↓
- BMI ↓
- Bp ↓
- Physical health ↑
- Cognitive control ↑
- Medication demands ↓
Patient safety: No adverse events were reported
Patient experiences/
Staff experiences:
Patient experiences: NA
Staff experiences: NA
Investment:
Equipment/Materials
- Glucometer
- Weight
- Step counter
Running:
Staff resources
- Weekly care calls
Organization: NA
Health care utilization: NA